Cryptogenic organizing pneumonia (COP) is a clinicopathologic syndrome char
acterized by rapid resolution with corticosteroids, but frequent relapses w
hen treatment is tapered or stopped. We retrospectively studied relapses in
48 cases of biopsy-proven COP. One or more relapses (mean 2.4 +/- 2.2) occ
urred in 58%. At first relapse, 68% of patients were still under treatment
for the initial episode. Compared with the no-relapse group, nine patients
with multiple (greater than or equal to 3) relapses had longer delays betwe
en first symptoms and treatment onset (22 +/- 17 versus 11 +/- 8 wk, p = 0.
02), and elevated gamma-glutamyltransferase (124 +/- 98 versus 29 +/- 13 IU
/L, p = 0.001) and alkaline phosphatase (190 +/- 124 versus 110 +/- 68 IU/L
, p = 0.04) levels. Relapses did not adversely affect outcome. Corticostero
id treatment side effects occurred in 25% of patients. Standardized treatme
nt in 14 patients allowed a reduction of prednisone cumulated doses (p < 0.
05) without affecting outcome or relapse rate. We conclude that: (1) delaye
d treatment increases the risk of relapses; (2) mild cholestasis identifies
a subgroup of patients with multiple relapses; (3) relapses do not affect
outcome, and prolonged therapy to suppress relapses appears unnecessary; (4
) a standardized treatment allows a reduction in steroid doses.